Search

William A. Craigo

Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
936
Issued Applications
383
Pending Applications
126
Abandoned Applications
445

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17828402 [patent_doc_number] => 20220265706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING COMPLEXES OF ALLOFERON AND ZINC [patent_app_type] => utility [patent_app_number] => 17/627741 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627741 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/627741
PHARMACEUTICAL COMPOSITION CONTAINING COMPLEXES OF ALLOFERON AND ZINC Dec 10, 2020 Abandoned
Array ( [id] => 20301223 [patent_doc_number] => 12447193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-21 [patent_title] => Compositions and methods for prevention and treatment of infections [patent_app_type] => utility [patent_app_number] => 17/102081 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 7192 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102081 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/102081
Compositions and methods for prevention and treatment of infections Nov 22, 2020 Issued
Array ( [id] => 16853628 [patent_doc_number] => 20210154373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => METHOD FOR IMMOBILIZING HEPARIN AND NO-GENERATING CATALYST AND CARDIOVASCULAR DEVICE HAVING SURFACE MODIFIED USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/952627 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952627 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/952627
METHOD FOR IMMOBILIZING HEPARIN AND NO-GENERATING CATALYST AND CARDIOVASCULAR DEVICE HAVING SURFACE MODIFIED USING THE SAME Nov 18, 2020 Abandoned
Array ( [id] => 17593322 [patent_doc_number] => 20220142895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => USE OF SALIDROSIDE DERIVATIVE IN EXTERNAL PREPARATION FOR SKIN WHITENING [patent_app_type] => utility [patent_app_number] => 17/432492 [patent_app_country] => US [patent_app_date] => 2020-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432492 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/432492
Use of salidroside derivative in external preparation for skin whitening Nov 17, 2020 Issued
Array ( [id] => 16822677 [patent_doc_number] => 20210137970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => NITRIC OXIDE-RELEASING PARTICLES [patent_app_type] => utility [patent_app_number] => 17/090637 [patent_app_country] => US [patent_app_date] => 2020-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090637 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/090637
NITRIC OXIDE-RELEASING PARTICLES Nov 4, 2020 Pending
Array ( [id] => 17602846 [patent_doc_number] => 11331315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Aripiprazole oral soluble film [patent_app_type] => utility [patent_app_number] => 17/087949 [patent_app_country] => US [patent_app_date] => 2020-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5782 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087949 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/087949
Aripiprazole oral soluble film Nov 2, 2020 Issued
Array ( [id] => 18018815 [patent_doc_number] => 20220370314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => AQUEOUS OXIDATIVE COMPOSITION COMPRISING XANTHINE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/773517 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6707 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773517 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/773517
AQUEOUS OXIDATIVE COMPOSITION COMPRISING XANTHINE DERIVATIVES Oct 29, 2020 Pending
Array ( [id] => 18064520 [patent_doc_number] => 20220395607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => SWELLABLE ANTIMICROBIAL FIBRE [patent_app_type] => utility [patent_app_number] => 17/771276 [patent_app_country] => US [patent_app_date] => 2020-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7404 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771276 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/771276
SWELLABLE ANTIMICROBIAL FIBRE Oct 21, 2020 Abandoned
Array ( [id] => 18018989 [patent_doc_number] => 20220370488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => MUCUS PENETRATING PARTICLE COMPOSITIONS AND METHODS OF USE THEREOF ENHANCING IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 17/770437 [patent_app_country] => US [patent_app_date] => 2020-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22609 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770437 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/770437
MUCUS PENETRATING PARTICLE COMPOSITIONS AND METHODS OF USE THEREOF ENHANCING IMMUNE RESPONSE Oct 20, 2020 Pending
Array ( [id] => 20401193 [patent_doc_number] => 12491152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Antiperspirant/deodorant compositions [patent_app_type] => utility [patent_app_number] => 17/763386 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5023 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763386 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/763386
Antiperspirant/deodorant compositions Oct 15, 2020 Issued
Array ( [id] => 16748729 [patent_doc_number] => 20210100738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => OXYGEN DELIVERY BEVERAGE [patent_app_type] => utility [patent_app_number] => 17/069394 [patent_app_country] => US [patent_app_date] => 2020-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10645 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069394 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/069394
OXYGEN DELIVERY BEVERAGE Oct 12, 2020 Abandoned
Array ( [id] => 16596519 [patent_doc_number] => 20210023050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => TESOFENSINE AND BETA BLOCKER COMBINATION FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/066843 [patent_app_country] => US [patent_app_date] => 2020-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13268 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066843 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/066843
Tesofensine and beta blocker combination formulations Oct 8, 2020 Issued
Array ( [id] => 16805983 [patent_doc_number] => 20210128536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => WEAKLY BASIC DRUG AND IONIC POLYMER PHARMACEUTICAL FORMULATIONS AND METHODS OF FORMATION AND ADMINISTRATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/065664 [patent_app_country] => US [patent_app_date] => 2020-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12839 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065664 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/065664
WEAKLY BASIC DRUG AND IONIC POLYMER PHARMACEUTICAL FORMULATIONS AND METHODS OF FORMATION AND ADMINISTRATION THEREOF Oct 7, 2020 Abandoned
Array ( [id] => 19777531 [patent_doc_number] => 12226552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Active agent depots formed in situ [patent_app_type] => utility [patent_app_number] => 17/038171 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 11096 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17038171 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/038171
Active agent depots formed in situ Sep 29, 2020 Issued
Array ( [id] => 20592360 [patent_doc_number] => 12576056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Amino acid-containing granules [patent_app_type] => utility [patent_app_number] => 17/761760 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4834 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761760 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761760
Amino acid-containing granules Sep 17, 2020 Issued
Array ( [id] => 17958504 [patent_doc_number] => 20220339084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => NEAR INFRARED BLOCKING AGENT AND NEAR INFRARED BLOCKING TOPICAL SKIN PREPARATION [patent_app_type] => utility [patent_app_number] => 17/762856 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3367 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762856 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/762856
NEAR INFRARED BLOCKING AGENT AND NEAR INFRARED BLOCKING TOPICAL SKIN PREPARATION Sep 17, 2020 Pending
Array ( [id] => 16718601 [patent_doc_number] => 20210085748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => Implantable medical device having a negatively-charged and antimicrobial surface [patent_app_type] => utility [patent_app_number] => 17/024343 [patent_app_country] => US [patent_app_date] => 2020-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1793 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024343 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/024343
Implantable medical device having a negatively-charged and antimicrobial surface Sep 16, 2020 Abandoned
Array ( [id] => 18341268 [patent_doc_number] => 11638737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-02 [patent_title] => Food compositions and pharmaceutical compositions containing [patent_app_type] => utility [patent_app_number] => 17/023447 [patent_app_country] => US [patent_app_date] => 2020-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10829 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023447 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/023447
Food compositions and pharmaceutical compositions containing Sep 16, 2020 Issued
Array ( [id] => 16718455 [patent_doc_number] => 20210085602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => INJECTABLE PHARMACEUTICAL FORMULATION [patent_app_type] => utility [patent_app_number] => 17/015415 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18832 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015415 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/015415
Injectable pharmaceutical formulation Sep 8, 2020 Issued
Array ( [id] => 16655944 [patent_doc_number] => 20210052580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => Combination Compositions and Therapies Comprising 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using Same [patent_app_type] => utility [patent_app_number] => 17/013142 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51813 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013142 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/013142
Combination Compositions and Therapies Comprising 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using Same Sep 3, 2020 Abandoned
Menu